Emerging and re-emerging KPC-producing hypervirulent Pseudomonas aeruginosa ST697 and ST463 between 2010 and 2021

References

• Hu FP, Guo Y, Zhu DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. Clin Microbiol Infect. 2016;22 Suppl 1:S9–14.
   PubMed Web of Science ®Google Scholar
• Micek ST, Wunderink RG, Kollef MH, et al. An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance. Crit Care. 2015;19:219.
   PubMed Web of Science ®Google Scholar
• Moradali MF, Ghods S, Rehm BH. Pseudomonas aeruginosa lifestyle: A paradigm for adaptation, survival, and persistence. Front Cell Infect Microbiol. 2017;7:39.
   PubMed Web of Science ®Google Scholar
• Pacheco T, Bustos-Cruz RH, Abril D, et al. Pseudomonas aeruginosa coharboring BlaKPC-2 and BlaVIM-2 carbapenemase genes. Antibiotics (Basel). 2019;8(3):98.
   PubMed Web of Science ®Google Scholar
• Lee AC, Jones AL. Multi-resistant Pseudomonas aeruginosa ST235 in cystic fibrosis. Paediatr Respir Rev. 2018;27:18–20.
   PubMed Web of Science ®Google Scholar
• Oliver A, Mulet X, Lopez-Causape C, et al. The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updat. 2015;21-22:41–59.
   PubMed Web of Science ®Google Scholar
• McCarthy K. Pseudomonas aeruginosa: evolution of antimicrobial resistance and implications for therapy. Semin Respir Crit Care Med. 2015;36(1):044–055.
   PubMed Web of Science ®Google Scholar
• Riera E, Cabot G, Mulet X, et al. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. J Antimicrob Chemother. 2011;66(9):2022–2027.
   PubMed Web of Science ®Google Scholar
• Castanheira M, Deshpande LM, Costello A, et al. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries. J Antimicrob Chemother. 2014;69(7):1804–1814.
   PubMed Web of Science ®Google Scholar
• Rossi Goncalves I, Dantas RCC, Ferreira ML, et al. Carbapenem-resistant Pseudomonas aeruginosa : association with virulence genes and biofilm formation. Braz J Microbiol. 2017;48(2):211–217.
   PubMed Web of Science ®Google Scholar
• Villegas MV, Lolans K, Correa A, et al. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother. 2007;51(4):1553–1555.
   PubMed Web of Science ®Google Scholar
• Akpaka PE, Swanston WH, Ihemere HN, et al. Emergence of KPC-producing Pseudomonas aeruginosa in Trinidad and Tobago. J Clin Microbiol. 2009;47(8):2670–2671.
   PubMed Web of Science ®Google Scholar
• Robledo IE, Aquino EE, Vazquez GJ. Detection of the KPC gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii during a PCR-based nosocomial surveillance study in Puerto Rico. Antimicrob Agents Chemother. 2011;55(6):2968–2970.
   PubMed Web of Science ®Google Scholar
• Cuzon G, Naas T, Nordmann P. Functional characterization of Tn4401, a Tn3-based transposon involved in blaKPC gene mobilization. Antimicrob Agents Chemother. 2011;55(11):5370–5373.
   PubMed Web of Science ®Google Scholar
• Poirel L, Walsh TR, Cuvillier V, et al. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123.
   PubMed Web of Science ®Google Scholar
• CLSI. Performance standards for antimicrobial susceptibility testing, 30th edition (M100S). Wayne (PA): CLSI; 2020.
   Google Scholar
• Liang Q, Jiang X, Hu L, et al. Sequencing and genomic diversity analysis of IncHI5 plasmids. Front Microbiol. 2019;9:3318.
   PubMed Web of Science ®Google Scholar
• Cotter G, Doyle S, Kavanagh K. Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol Med Microbiol. 2000;27(2):163–169.
   PubMedGoogle Scholar
• Chavez-Jacobo VM, Hernandez-Ramirez KC, Romo-Rodriguez P, et al. CrpP is a novel ciprofloxacin-modifying enzyme encoded by the Pseudomonas aeruginosa pUM505 plasmid. Antimicrob Agents Chemother. 2018;62(6):e02629-17.
   PubMed Web of Science ®Google Scholar
• Ito R, Mustapha MM, Tomich AD, et al. Widespread fosfomycin resistance in gram-negative bacteria attributable to the chromosomal fosA gene. mBio. 2017;8(4):e00749-17.
   PubMed Web of Science ®Google Scholar
• Zhu X, Li P, Qian C, et al. Prevalence of aminoglycoside resistance genes and molecular characterization of a novel gene, aac(3)-IIg, among clinical isolates of the Enterobacter cloacae complex from a Chinese teaching hospital. Antimicrob Agents Chemother. 2020;64(9):e00852-20.
   PubMed Web of Science ®Google Scholar
• Sharma VK, Johnson N, Cizmas L, et al. A review of the influence of treatment strategies on antibiotic resistant bacteria and antibiotic resistance genes. Chemosphere. 2016;150:702–714.
   PubMed Web of Science ®Google Scholar
• Gao P, Xu W, Ruan X, et al. Long-term impact of a tetracycline concentration gradient on the bacterial resistance in anaerobic-aerobic sequential bioreactors. Chemosphere. 2018;205:308–316.
   PubMed Web of Science ®Google Scholar
• Ozkaya E, Aydin F, Bayramoglu G, et al. Investigation of integrons, sul1-2 and dfr genes in trimethoprim-sulfametoxazole-resistant Stenotrophomonas maltophilia strains isolated from clinical samples. Mikrobiyol Bul. 2014;48(2):201–212.
   PubMed Web of Science ®Google Scholar
• Blackwell GA, Holt KE, Bentley SD, et al. Variants of AbGRI3 carrying the armA gene in extensively antibiotic-resistant Acinetobacter baumannii from Singapore. J Antimicrob Chemother. 2017;72(4):1031–1039.
   PubMed Web of Science ®Google Scholar
• Rafaque Z, Dasti JI, Andrews SC. Draft genome sequence of a uropathogenic Escherichia coli isolate (ST38 O1:H15) from Pakistan, an emerging multidrug-resistant sequence type with a high virulence profile. New Microbes New Infect. 2019;27:1–2.
   PubMedGoogle Scholar
• Jiang X, Yin Z, Yuan M, et al. Plasmids of novel incompatibility group IncpRBL16 from Pseudomonas species. J Antimicrob Chemother. 2020;75(8):2093–2100.
   PubMed Web of Science ®Google Scholar
• Zhan Z, Hu L, Jiang X, et al. Plasmid and chromosomal integration of four novel blaIMP-carrying transposons from Pseudomonas aeruginosa, Klebsiella pneumoniae and an Enterobacter sp. J Antimicrob Chemother. 2018;73(11):3005–3015.
   PubMed Web of Science ®Google Scholar
• Stokes HW, Elbourne LD, Hall RM. Tn1403, a multiple-antibiotic resistance transposon made up of three distinct transposons. Antimicrob Agents Chemother. 2007;51(5):1827–1829.
   PubMed Web of Science ®Google Scholar
• Wang D, Zhu J, Zhou K, et al. Genetic characterization of novel class 1 Integrons In0, In1069 and In1287 to In1290, and the inference of In1069-associated integron evolution in Enterobacteriaceae. Antimicrob Resist Infect Control. 2017;6:84.
   PubMed Web of Science ®Google Scholar
• Dobiasova H, Videnska P, Dolejska M. Complete sequences of IncU plasmids harboring quinolone resistance genes qnrS2 and aac(6’)-Ib-cr in Aeromonas spp. from ornamental fish. Antimicrob Agents Chemother. 2016;60(1):653–657.
   PubMed Web of Science ®Google Scholar
• Ramarao N, Nielsen-Leroux C, Lereclus D. The insect Galleria mellonella as a powerful infection model to investigate bacterial pathogenesis. J Vis Exp. 2012;70:e4392.
   Google Scholar
• Tsai CJ, Loh JM, Proft T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence. 2016;7(3):214–229.
   PubMed Web of Science ®Google Scholar
• Sanchez-Diener I, Zamorano L, Lopez-Causape C, et al. Interplay among resistance profiles, high-risk clones, and virulence in the caenorhabditis elegans Pseudomonas aeruginosa infection model. Antimicrob Agents Chemother. 2017;61(12):e01586-17.
   PubMed Web of Science ®Google Scholar
• Nathwani D, Raman G, Sulham K, et al. Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2014;3(1):32.
   PubMed Web of Science ®Google Scholar
• Rosenthal VD, Al-Abdely HM, El-Kholy AA, et al. International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: device-associated module. Am J Infect Control. 2016;44(12):1495–1504.
   PubMed Web of Science ®Google Scholar
• Reece E, Segurado R, Jackson A, et al. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis. BMC Pulm Med. 2017;17(1):70.
   PubMedGoogle Scholar
• Callejas-Diaz A, Fernandez-Perez C, Ramos-Martinez A, et al. Impacto de la bacteriemia por Pseudomonas aeruginosa en un hospital de tercer nivel: mortalidad y factores pronósticos. Med Clin (Barc). 2019;152(3):83–89.
   PubMedGoogle Scholar
• McCarthy KL, Paterson DL. Long-term mortality following Pseudomonas aeruginosa bloodstream infection. J Hosp Infect. 2017;95(3):292–299.
   PubMed Web of Science ®Google Scholar
• Rosanova MT, Mussini MS, Arias AP, et al. Epidemiological features and risk factors for mortality in Pseudomonas aeruginosa bacteremia in children. Arch Argent Pediatr. 2019;117(2):128–131.
   PubMed Web of Science ®Google Scholar
• Gaete ME, Valenzuela MP, Bachero AW, et al. Carbapenemasas en Pseudomonas aeruginosa con susceptibilidad disminuida a los carbapenémicos después de una década, desde VIM a KPC. Rev Chilena Infectol. 2020;37(4):389–394.
   PubMedGoogle Scholar
• Cai B, Echols R, Magee G, et al. Prevalence of carbapenem-resistant gram-negative infections in the United States predominated by acinetobacter baumannii and Pseudomonas aeruginosa. Open Forum Infect Dis. 2017;4(3):ofx176.
   PubMedGoogle Scholar
• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327.
   PubMed Web of Science ®Google Scholar
• Wang LJ, Chen EZ, Yang L, et al. Emergence of clinical Pseudomonas aeruginosa isolate Guangzhou-PaeC79 carrying crpP, blaGES-5, and blaKPC-2 in Guangzhou of China. Microb Drug Resist. 2021;27(7):965–970.
   PubMed Web of Science ®Google Scholar
• Yuan M, Guan H, Sha D, et al. Characterization of blaKPC-2-carrying plasmid pR31-KPC from a Pseudomonas aeruginosa strain isolated in China. Antibiotics (Basel). 2021;10(10):1234.
   PubMed Web of Science ®Google Scholar
• Cai H, Zhu Y, Hu D, et al. Co-harboring of novel blaKPC–2 plasmid and integrative and conjugative element carrying Tn6203 in multidrug-resistant Pseudomonas aeruginosa. Front Microbiol. 2021;12:674974.
   PubMedGoogle Scholar
• Feng W, Huang Q, Wang Y, et al. Changes in the resistance and epidemiological characteristics of Pseudomonas aeruginosa during a ten-year period. J Microbiol Immunol Infect. 2021;54(2):261–266.
   PubMedGoogle Scholar
• Hu Y, Peng W, Wu Y, et al. A potential high-risk clone of Pseudomonas aeruginosa ST463. Front Microbiol. 2021;12:670202.
   PubMedGoogle Scholar
• Hu Y, Liu C, Wang Q, et al. Emergence and expansion of a carbapenem-resistant Pseudomonas aeruginosa clone are associated with plasmid-borne bla KPC-2 and virulence-related genes. mSystems. 2021;6(3):e00154-21.
   PubMed Web of Science ®Google Scholar
• Botelho J, Grosso F, Peixe L. Antibiotic resistance in Pseudomonas aeruginosa - mechanisms, epidemiology and evolution. Drug Resist Updat. 2019;44:100640.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Chen J, Shen H, et al. Emergence of ceftazidime- and avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Pseudomonas aeruginosa in China. mSystems. 2021;6(6):e0078721.
   PubMed Web of Science ®Google Scholar
• Zheng D, Wang X, Wang P, et al. Genome sequence of pseudomonas citronellolis SJTE-3, an estrogen- and polycyclic aromatic hydrocarbon-degrading bacterium. Genome Announc. 2016;4(6):e01373-16.
   PubMedGoogle Scholar
• Sanchez-Diener I, Zamorano L, Pena C, et al. Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections. Clin Microbiol Infect. 2020;26(3):351–357.
   PubMed Web of Science ®Google Scholar
• Pena C, Cabot G, Gomez-Zorrilla S, et al. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections. Clin Infect Dis. 2015;60(4):539–548.
   PubMed Web of Science ®Google Scholar
• Cholley P, Ka R, Guyeux C, et al. Population structure of clinical Pseudomonas aeruginosa from West and Central African countries. PLoS One. 2014;9(9):e107008.
   PubMed Web of Science ®Google Scholar
• Kazmierczak KM, de Jonge BLM, Stone GG, et al. In vitro activity of ceftazidime/avibactam against isolates of Pseudomonas aeruginosa collected in European countries: INFORM global surveillance 2012-15. J Antimicrob Chemother. 2018;73(10):2777–2781.
   PubMed Web of Science ®Google Scholar
• Hu YY, Gu DX, Cai JC, et al. Emergence of KPC-2-producing Pseudomonas aeruginosa sequence type 463 isolates in Hangzhou, China. Antimicrob Agents Chemother. 2015;59(5):2914–2917.
   PubMed Web of Science ®Google Scholar